Literature DB >> 21980258

Durable remission of inoperable liver metastasis from rectal cancer after hepatic arterial infusion of oxaliplatin and 5-fluorouracil in combination with intravenous cetuximab.

K Van Bael1, M Aerts, M de Ridder, J de Gréve, G Delvaux, B Neyns.   

Abstract

At diagnosis of a cT3N0M1 adenocarcinoma of the rectum with synchronous inoperable liver metastases, a 59-year-old man was treated with preoperative radiotherapy (5×5 Gy), followed by laparoscopy-assisted anterior resection of the rectum with total mesorectal excision. At the first postoperative evaluation, a new lung metastasis was detected. First-line chemotherapy with folfiri (5-fluorouracil, irinotecan, leucovorin) resulted in transient stabilization of the metastatic liver disease. At progression, oxaliplatin and 5-fluorouracil-folinic acid were administered by intrahepatic arterial infusion, in combination with intravenous cetuximab. A partial radiologic response was obtained, with complete metabolic response on fluorodeoxyglucose positron-emission tomography, and normalization of carcinoembryonic antigen values. The solitary lung metastasis was sequentially treated with radiotherapy and resection. Five years after the initial diagnosis, this patient remains free from progression, with residual cystic remnants of the liver metastases visible on conventional computed tomography imaging, but not enhancing with fluorodeoxyglucose positron-emission tomography.

Entities:  

Keywords:  Hepatic arterial infusion; cetuximab; colorectal; liver metastases; oxaliplatin; remission

Year:  2011        PMID: 21980258      PMCID: PMC3185908          DOI: 10.3747/co.v18i5.789

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  16 in total

1.  Techniques for the placement of hepatic artery catheters for regional chemotherapy in unresectable liver metastases.

Authors:  Y Van Nieuwenhove; M Aerts; B Neyns; G Delvaux
Journal:  Eur J Surg Oncol       Date:  2006-11-03       Impact factor: 4.424

Review 2.  Role of adjuvant therapy after resection of colorectal cancer liver metastases.

Authors:  Derek G Power; Nancy E Kemeny
Journal:  J Clin Oncol       Date:  2010-04-05       Impact factor: 44.544

3.  Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial.

Authors:  David J Kerr; Colin S McArdle; Jonathan Ledermann; Irving Taylor; David J Sherlock; Peter M Schlag; John Buckels; David Mayer; Dionne Cain; Richard J Stephens
Journal:  Lancet       Date:  2003-02-01       Impact factor: 79.321

4.  Patients with initially unresectable colorectal liver metastases: is there a possibility of cure?

Authors:  René Adam; Dennis A Wicherts; Robbert J de Haas; Oriana Ciacio; Francis Lévi; Bernard Paule; Michel Ducreux; Daniel Azoulay; Henri Bismuth; Denis Castaing
Journal:  J Clin Oncol       Date:  2009-03-09       Impact factor: 44.544

5.  Actual 10-year survival after resection of colorectal liver metastases defines cure.

Authors:  James S Tomlinson; William R Jarnagin; Ronald P DeMatteo; Yuman Fong; Peter Kornprat; Mithat Gonen; Nancy Kemeny; Murray F Brennan; Leslie H Blumgart; Michael D'Angelica
Journal:  J Clin Oncol       Date:  2007-10-10       Impact factor: 44.544

6.  Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

Authors:  Leonard B Saltz; Stephen Clarke; Eduardo Díaz-Rubio; Werner Scheithauer; Arie Figer; Ralph Wong; Sheryl Koski; Mikhail Lichinitser; Tsai-Shen Yang; Fernando Rivera; Felix Couture; Florin Sirzén; Jim Cassidy
Journal:  J Clin Oncol       Date:  2008-04-20       Impact factor: 44.544

Review 7.  Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era?

Authors:  Simone Mocellin; Pierluigi Pilati; Mario Lise; Donato Nitti
Journal:  J Clin Oncol       Date:  2007-12-10       Impact factor: 44.544

Review 8.  Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer.

Authors:  Simone Mocellin; Sandro Pasquali; Donato Nitti
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

9.  Cetuximab with hepatic arterial infusion of chemotherapy for the treatment of colorectal cancer liver metastases.

Authors:  Bart Neyns; Maridi Aerts; Yves Van Nieuwenhove; Christel Fontaine; Lore De Coster; Dennis Schallier; Jacques Vanderauwera; Floris De Munck; Frederik Vandenbroucke; Hendrik Everaert; Vanessa Meert; Johan De Mey; Mark De Ridder; Georges Delvaux; Jacques De Grève
Journal:  Anticancer Res       Date:  2008 Jul-Aug       Impact factor: 2.480

10.  Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial.

Authors:  Bernard Nordlinger; Halfdan Sorbye; Bengt Glimelius; Graeme J Poston; Peter M Schlag; Philippe Rougier; Wolf O Bechstein; John N Primrose; Euan T Walpole; Meg Finch-Jones; Daniel Jaeck; Darius Mirza; Rowan W Parks; Laurence Collette; Michel Praet; Ullrich Bethe; Eric Van Cutsem; Werner Scheithauer; Thomas Gruenberger
Journal:  Lancet       Date:  2008-03-22       Impact factor: 79.321

View more
  1 in total

1.  A Case Report of Long-Term Survival following Hepatic Arterial Infusion of L-Folinic Acid Modulated 5-Fluorouracil Combined with Intravenous Irinotecan and Cetuximab Followed by Hepatectomy in a Patient with Initially Unresectable Colorectal Liver Metastases.

Authors:  Kobe Van Bael; Yanina Jansen; Teofila Seremet; Benedikt Engels; Georges Delvaux; Bart Neyns
Journal:  Case Rep Oncol Med       Date:  2015-05-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.